Metabolism and selective toxicity of 6-nitrobenzylthioinosine in Toxoplasma gondii

Antimicrobial Agents and Chemotherapy

Volumn 43, Issue 10, 1999, Pages 2437-2443

  El Kouni, Mahmoud H ^a   Guarcello, Vincenzo ^a   Al Safarjalani, Omar N ^a   Naguib, Fardos N M ^a  

^a The Purdue Univ Univ of Alabama at Birmingham Botanical Center for Age Related Disease   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE KINASE; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; NITROBENZYLTHIOINOSINE; PURINE NUCLEOSIDE;

ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HOST CELL; HUMAN; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; PURINE METABOLISM; TOXICITY TESTING; TOXOPLASMA GONDII; TOXOPLASMOSIS;

EID: 0032822923     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.43.10.2437     Document Type: Article

References (27)

1. Bermudes, D., K. R. Peck, M. A. Afifi, C. J. M. Beckers, and K. A. Joiner. 1994. Tandemly repeated genes encode nucleoside triphosphate hydrolase isoforms secreted into the parasitophorous vacuole of Toxoplasma gondii. J. Biol. Chem. 46:29252-29260.
2. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
3. el Kouni, M. H., D. Diop, and S. Cha. 1983. Combination therapy of schistosomiasis by tubercidin and nitrobenzylthioinosine 5′-monophosphate. Proc. Natl. Acad. Sci. USA 80:6667-6670.
4. el Kouni, M. H., P. M. Knopf, and S. Cha. 1985. Combination therapy of Schistosoma japonicum by tubercidin and nitrobenzylthioinosine 5′-monophosphate. Biochem. Pharmacol. 34:3921-3923.
5. el Kouni, M. H., and S. Cha. 1987. Metabolism of adenosine analogues by Schistosoma mansoni and the effect of nucleoside transport inhibitors. Biochem. Pharmacol. 36:1099-1106.
6. el Kouni, M. H., N. J. Messier, and S. Cha. 1987. Treatment of schistosomiasis by purine nucleoside analogues in combination with nucleoside transport inhibitors. Biochem. Pharmacol. 36:3815-3821.
7. el Kouni, M. H., D. Diop, P. O'Shea, R. Carlisle, and J.-P. Sommadossi. 1989. Prevention of tubercidin host toxicity by nitrobenzylthioinosine 5′-monophosphate for the treatment of schistosomiasis. Antimicrob. Agents Chemother. 33:824-827.
8. el Kouni, M. H. 1991. Efficacy of combination therapy with tubercidin and nitrobenzylthioinosine 5′-monophosphate against chronic and advanced stages of schistosomiasis. Biochem. Pharmacol. 41:815-820.
9. el Kouni, M. H., V. Guarcello, O. N. Al Safarjalani, and F. N. M. Naguib. 1998. Metabolism and selective toxicity of 6-nitrobenzylthioinosine in Toxoplasma gondii. FASEB J. 12:A126.
10. Gati, W. P, A. F. W. Stoyke, A. M. Gero, and A. R. P. Paterson. 1987. Nucleoside permeation in mouse erythrocytes infected with Plasmodium yoelii. Biochem. Biophys. Res. Commun. 145:1134-1141.
11. Gero, A. M., E. M. A. Bugledich, A. R. P. Paterson, and G. P. Jamieson. 1988. Stage-specific alteration of nucleoside membrane permeability and nitrobenzylthioinosine insensitivity in Plasmodium falciparum infected erythrocytes. Mol. Biochem. Parasitol. 27:159-170.
12. Iltzsch, M. H., S. S. Uber, K. O. Tankersley, and M. H. el Kouni. 1995. Structure-activity relationship for the binding of nucleoside ligands to adenosine kinase from Toxoplasma gondii. Biochem. Pharmacol. 49:1501-1512.
13. Kolassa, N., E. S. Jakobs, G. R. Buzzell, and A. R. P. Paterson. 1982. Manipulation of toxicity and tissue distribution of tubercidin in mice by nitrobenzylthioinosine 5′-monophosphate. Biochem. Pharmacol. 31:1863-1874.
14. Krug, E. C., J. J. Marr, and R. L. Berens. 1989. Purine metabolism in Toxoplasma gondii. J. Biol. Chem. 264:10601-10607.
15. Luft, B. J., and J. S. Remington. 1992. AIDS commentary: toxoplasmic encephalitis in AIDS. Clin. Infect. Dis. 15:211-222.
16. Miller, R. L., D. L. Adamczyk, J. L. Rideont, and T. A. Krenitsky. 1982. Purification, characterization, substrate and inhibitor specificity of adenosine kinase from several Eimeria species. Mol. Biochem. Parasitol. 6:209-223.
17. Naguib, F. N. M., M. H. Iltzsch, M. M. el Kouni, R. P. Panzica, and M. H. el Kouni. 1995. Structure-activity relationships for the binding of ligands to xanthine or guanine phosphoribosyl-transferase from Toxoplasma gondii. Biochem. Pharmacol. 50:1685-1693.
18. Perrotto, J., D. B. Keister, and A. H. Gelderman. 1971. Incorporation of precursors into Toxoplasma DNA. J. Protozool. 18:470-473.
19. Pfefferkorn, E. R., and L. C. Pfefferkorn. 1977. Specific labeling of intracellular Toxoplasma gondii with uracil. J. Protozool. 24:449-453.
20. Pfefferkorn, E. R., and L. C. Pfefferkorn. 1978. The biochemical basis for resistance to adenine arabinoside in a mutant of Toxoplasma gondii. J. Parasitol. 64:4:486-492.
21. Pfefferkorn, E. R., and S. E. Borotz. 1994. Toxoplasma gondii: characterization of a mutant resistant to 6-thioxanthine. Exp. Parasitol. 79:374-382.
22. Remington, J. S., and G. Desmonts. 1995. Toxoplasmosis, p. 140-267. In J. S. Remington and J. O. Klein (ed.), Infectious diseases of the fecus and newborn infant, 4th ed. The W. B. Saunders Co., Philadelphia, Pa.
23. Schwab, J. C., C. J. M. Beckers, and K. A. Joiner. 1994. The parasitophorous vacuole membrane surrounding intracellular Toxoplasma gondii as a membrane sieve. Proc. Natl. Acad. Sci. USA 91:509-513.
24. Schwartzman, J. D., and E. R. Pfefferkorn. 1982. Toxoplasma gondii: purine synthesis and salvage in mutant host cells and parasites. Exp. Parasitol. 53:77-86.
25. Subauste, C. S., and J. S. Remington. 1993. Immunity to Toxoplasma gondii. Curr. Opin. Immunol. 5:532-537.
26. Upston, J. M., and A. M. Gero. 1995. Parasite induced permeation of nucleosides in Plasmodium falciparum malaria. Biochim. Biophys. Acta 1236:249-258.
27. Wong, S., and J. S. Remington. 1993. Biology of Toxoplasma gondii. AIDS 7:299-316.